Skip to content
Study details
Enrolling now

Pivotal Study of the Velocity™ pAVF System

Venova Medical
NCT IDNCT07153939ClinicalTrials.gov data as of Apr 2026
Target enrollment

126

Study length

about 4.9 years

Ages

18–80

Locations

10 sites in AL, CA, FL +2

What this study is about

Researchers are testing a new way to create dialysis access called the Velocity Percutaneous Arteriovenous Fistula (pAVF) System. It's a minimally invasive procedure that uses a catheter instead of surgery. The trial will follow participants for up to five years to see how safe and effective this new method is.

Simplified from trial records by PatientMatch.

What you may be asked to do

  • 1.Use Velocity Percutaneous Arteriovenous Fistula

Participation Burden

What's physically and logistically required of participants.

Logistics & Travel
In-person visits

Requires travel to a study site

Physical Intervention
Standard

How treatment is administered

Treatment Assignment
All receive treatment

Everyone gets the investigational treatment.

Extracted study details

Pulled from the trial record to show what is being tested and what the study is measuring.

Endpoints

Secondary: Freedom from Serious Adverse Events, Procedural Success, Technical Success

Body systems

Renal